Reaction profile

The FDA adverse-event record for reduced responses

924 FDA reports name reduced responses, a high-volume reaction in the CVM extract (VeDDRA 1021). Plate stamps and neighbourhood peers follow.

#418 of 2,481
by report volume (all reactions)
924
reports citing this reaction
25.2%
death-coded share
Dog
most-affected species

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Reduced responses has 924 reports now versus 910 in that prior snapshot: 14 more (1.5%).

Report change
+14
Death-coded reports
+3
Death-coded share
−0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Reduced responses changes

FDA AER · VeDDRA plate

Code 1021 VOL-MID

VOL-MID · DEATH-HOT · UPPER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL

  • VOL-MID 924 reports
  • DEATH-HOT 25.2%
  • UPPER-Q #418/2481
  • PHOTO-FINISH Knuckling
  • SPECIES-DOG Dog · 756
  • DRUG-LEAD Milbemycin Oxime… · 243
  • DESK-WIDE 20 breeds
  • BOOK-FULL 8/8 fields

Nearest volume peer: Knuckling (±1 reports)

Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.

High-volume neighbourhood around Reduced responses

Upper-third volume poles plus nearest peers, not a full reaction corpus board reprint.

Vomiting · highest174348Lip licking · near928Hyperalbuminaemia · near927Reduced responses · this rea…924Knuckling · near923Abnormal adrenocortic… · near920Urinary tract neoplas… · low…10
FDA AER report volume · neighbourhood around Reduced responses

Reduced responses: high death-coded share in the FDA AER plate

Signature read: 233 death-coded reports is a heavy tail count for Reduced responses in the CVM extract. Report volume is upper-third scale: 924 named reports in the openFDA extract. Death-coded share is upper-third: 233 of 924 reports (25.2% of named reports). Nearest volume peer: Knuckling (±1 reports). Lead species Dog (756). Lead co-reported drug Milbemycin Oxime + Spinosad (243).

Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.

Species Most Affected

Dog 756
Cat 162
Cattle 2
Hedgehog 1
Human 1
Rabbit 1
Rat 1

Breeds Most Affected

Domestic Shorthair 82
Retriever - Labrador 71
Chihuahua 47
Terrier - Yorkshire 44
Crossbred Canine/dog 39
Retriever - Golden 34
Boxer (German Boxer) 29
Shih Tzu 24
Domestic Longhair 21
Pug 20

Associated Drugs

Milbemycin Oxime + Spinosad 243
Maropitant Citrate 71
Carprofen 67
Spinosad 62
Moxidectin 55
Afoxolaner 51
Cefovecin 47
Bedinvetmab 31
Ivermectin + Pyrantel As Pamoate Salt 29
Famotidine 27
Buprenorphine 26
Dexamethasone 25
Selamectin 25
Isoflurane 22
Rabies Virus, Kv 21
Oclacitinib Maleate 20
Prednisone 19
Tramadol 19
Diphenhydramine Hcl 19
Fluralaner Chew Tablets 18

Nationwide reactions with similar profiles

Two openFDA-derived peer sets for Reduced responses, both floored at ≥50 reports so the neighborhoods stay in the advertised mass (the volume chart above is the unfloored photo-finish strip).

What to do with this reaction

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Reduced responses (#418 of 2,481 by report volume); death-coded 25.2%. PlainBreed reaction plate · death-coded report count stamp 233 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →